Brief: Allergy Therapeutics Appoints Shaun Furlong As Chief Financial Officer
July 10 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ALLERGY THERAPEUTICS - APPOINTMENT OF CHIEF FINANCIAL
OFFICER
* ALLERGY THERAPEUTICS PLC - PROMOTION OF SHAUN FURLONG TO
CHIEF
FINANCIAL OFFICER
* ALLERGY THERAPEUTICS PLC - CURRENT INTERIM CFO, MARTIN
HOPCROFT, WILL LEAVE COMPANY.
Source text for Eikon: ID:nRSJ5339Fa
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update